J. R. Krevans

562 total citations
11 papers, 375 citations indexed

About

J. R. Krevans is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, J. R. Krevans has authored 11 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in J. R. Krevans's work include Blood groups and transfusion (6 papers), Hemoglobinopathies and Related Disorders (4 papers) and Diabetes and associated disorders (1 paper). J. R. Krevans is often cited by papers focused on Blood groups and transfusion (6 papers), Hemoglobinopathies and Related Disorders (4 papers) and Diabetes and associated disorders (1 paper). J. R. Krevans collaborates with scholars based in United States and United Kingdom. J. R. Krevans's co-authors include R. Finn, J. C. Woodrow, C. Lockard Conley, W. T. A. Donohoe, Daniel E. Lehane, P. M. Sheppard, R. B. McConnell, Cyril Clarke, W. Kulke and Calvin A. Lang and has published in prestigious journals such as Annals of Internal Medicine, JNCI Journal of the National Cancer Institute and Transfusion.

In The Last Decade

J. R. Krevans

10 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. R. Krevans United States	8	198	103	79	74	63	11	375
Irving Umansky United States	7	138 0.7×	51 0.5×	51 0.6×	107 1.4×	43 0.7×	11	326
Daniel H. Coleman United States	6	172 0.9×	142 1.4×	92 1.2×	30 0.4×	16 0.3×	8	377
Güngör Nişli Türkiye	10	185 0.9×	124 1.2×	24 0.3×	60 0.8×	20 0.3×	23	287
Delores Mallory United States	12	354 1.8×	91 0.9×	164 2.1×	34 0.5×	112 1.8×	35	463
E. O. Gaston United States	6	72 0.4×	52 0.5×	62 0.8×	16 0.2×	27 0.4×	8	189
J.R. Kendra United Kingdom	9	216 1.1×	43 0.4×	12 0.2×	28 0.4×	58 0.9×	11	319
Akemi Kuroda Chiba Brazil	13	221 1.1×	59 0.6×	102 1.3×	55 0.7×	133 2.1×	42	396
Serjeant Gr Jamaica	11	293 1.5×	344 3.3×	27 0.3×	75 1.0×	7 0.1×	23	411
R Musso Italy	12	303 1.5×	71 0.7×	18 0.2×	17 0.2×	18 0.3×	17	412
E.S. Curtoni Italy	10	73 0.4×	17 0.2×	17 0.2×	9 0.1×	183 2.9×	21	339

Countries citing papers authored by J. R. Krevans

Since Specialization

Citations

This map shows the geographic impact of J. R. Krevans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. R. Krevans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. R. Krevans more than expected).

Fields of papers citing papers by J. R. Krevans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. R. Krevans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. R. Krevans. The network helps show where J. R. Krevans may publish in the future.

Co-authorship network of co-authors of J. R. Krevans

This figure shows the co-authorship network connecting the top 25 collaborators of J. R. Krevans. A scholar is included among the top collaborators of J. R. Krevans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. R. Krevans. J. R. Krevans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Krevans, J. R. & Dudley P. Jackson. (2015). Survival of Platelets Transfused into Thrombocytopenic Recipients*. Proceedings of the International Society of Blood Transfusion. 107. 355–356.

2.

Krevans, J. R., et al.. (1970). Hematologic changes in septicemia.. PubMed. 126(2). 69–76. 10 indexed citations

3.

Woodrow, J. C., R. Finn, & J. R. Krevans. (1969). Rapid Clearance of Rh Positive Blood During Experimental Rh Immunisation. Vox Sanguinis. 17(5). 349–361. 16 indexed citations

4.

Bias, Wilma Β., et al.. (1969). The Stoltzfus blood group, a new polymorphism in man.. PubMed. 21(6). 552–8. 3 indexed citations

5.

Donohoe, W. T. A., R. Finn, Rob McConnell, et al.. (1966). Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.. BMJ. 2(5519). 907–914. 46 indexed citations

6.

Clarke, Cyril, W. T. A. Donohoe, R. B. McConnell, et al.. (1963). Further Experimental Studies on the Prevention of Rh Haemolytic Disease. BMJ. 1(5336). 979–984. 153 indexed citations

7.

Strumia, Max M., et al.. (1963). GENERAL PRINCIPLES OF BLOOD TRANSFUSION. Transfusion. 3(S1). 303–346. 23 indexed citations

8.

Krevans, J. R., et al.. (1961). The homozygous state of persistent fetal hemoglobin and the interaction of persistent fetal hemoglobin with thalassemia.. PubMed. 109. 217–33. 48 indexed citations

9.

Conley, C. Lockard & J. R. Krevans. (1955). NEW DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF PERNICIOUS ANEMIA. Annals of Internal Medicine. 43(4). 758–766. 23 indexed citations

10.

Conley, C. Lockard, J. R. Krevans, Bacon F. Chow, C. H. Barrows, & Calvin A. Lang. (1951). Observations on the absorption, utilization, and excretion of vitamin B12.. PubMed. 38(1). 84–94. 47 indexed citations

11.

Krevans, J. R., et al.. (1951). Electrophoretically Determined Blood-Protein Levels in a Case of Acute Myelogenous Leukemia under Exchange Transfusion Treatment. JNCI Journal of the National Cancer Institute. 12(2). 323–35. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact